KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Mar 22, 2023 $3.05 $3.08 $2.94 $2.95 761 394
Mar 21, 2023 $3.06 $3.08 $2.98 $3.03 621 605
Mar 20, 2023 $3.02 $3.02 $2.88 $3.02 733 919
Mar 17, 2023 $2.95 $3.06 $2.91 $2.99 2 622 188
Mar 16, 2023 $3.02 $3.02 $2.91 $2.94 892 428
Mar 15, 2023 $2.98 $3.07 $2.97 $3.03 915 137
Mar 14, 2023 $3.02 $3.08 $2.97 $3.03 1 955 741
Mar 13, 2023 $2.73 $3.01 $2.73 $2.96 1 683 512
Mar 10, 2023 $2.83 $2.85 $2.63 $2.80 2 336 104
Mar 09, 2023 $2.93 $2.96 $2.82 $2.83 677 326
Mar 08, 2023 $2.94 $2.97 $2.90 $2.95 856 715
Mar 07, 2023 $2.90 $2.94 $2.85 $2.93 538 771
Mar 06, 2023 $2.86 $2.90 $2.83 $2.88 896 787
Mar 03, 2023 $2.80 $3.03 $2.79 $2.86 1 323 723
Mar 02, 2023 $2.81 $2.81 $2.71 $2.81 443 788
Mar 01, 2023 $2.71 $2.86 $2.71 $2.81 1 258 021
Feb 28, 2023 $2.65 $2.84 $2.63 $2.78 2 154 771
Feb 27, 2023 $2.65 $2.66 $2.57 $2.65 731 425
Feb 24, 2023 $2.68 $2.71 $2.63 $2.65 849 446
Feb 23, 2023 $2.78 $2.78 $2.70 $2.74 1 149 959
Feb 22, 2023 $2.76 $2.78 $2.72 $2.76 890 375
Feb 21, 2023 $2.70 $2.78 $2.67 $2.76 1 471 124
Feb 17, 2023 $2.66 $2.75 $2.64 $2.74 2 005 120
Feb 16, 2023 $2.68 $2.72 $2.65 $2.65 727 821
Feb 15, 2023 $2.66 $2.73 $2.64 $2.72 652 553
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT